Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Shares, $0.01 par value
-
Shares outstanding
-
28,862,386
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
2,226,005
-
Shares change
-
-211,237
-
Total reported value, excl. options
-
$38,335,000
-
Value change
-
-$3,729,087
-
Number of buys
-
19
-
Number of sells
-
-22
-
Price
-
$17.19
Significant Holders of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) as of Q2 2016
50 filings reported holding HQL - abrdn Life Sciences Investors - Common Shares, $0.01 par value as of Q2 2016.
abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,226,005 shares
of 28,862,386 outstanding shares and own 7.71% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (559,985 shares), NEEDHAM INVESTMENT MANAGEMENT LLC (502,932 shares), WELLS FARGO & COMPANY/MN (233,936 shares), LPL Financial LLC (76,233 shares), UBS Group AG (74,484 shares), BANK OF NOVA SCOTIA (71,984 shares), Advisors Asset Management, Inc. (70,799 shares), STIFEL FINANCIAL CORP (69,733 shares), FIRST TRUST ADVISORS LP (57,744 shares), and LADENBURG THALMANN FINANCIAL SERVICES INC (46,191 shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.